DeepMed Research

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

PXVX0200 (CVD103-HgR) vs Shanchol in Mali

Phase 2

Completed

Conditions: Cholera

Interventions: Biological: Shanchol
Biological: PXVX0200 10E9
Biological: PXVX0200 10E8
Biological: Placebo

First Posted Date: 2014-05-22

Last Posted Date: 2019-09-26

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 150

Registration Number: NCT02145377

Locations: 🇲🇱
Centre pour le Développement des Vaccins, Mali (CVD-Mali), Bamako, Mali

L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder

Phase 2

Withdrawn

Conditions: Cocaine Use

Interventions: Drug: l-tetrahydropalmatine (l-THP)
Drug: Placebo

First Posted Date: 2014-05-15

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT02139761

Locations: 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Managing Acute Pain in Critically Ill Non-communicative Palliative Care Patients

Not Applicable

Completed

Conditions: Critically Ill

Interventions: Other: Intervention Group

First Posted Date: 2014-04-30

Last Posted Date: 2022-03-21

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 377

Registration Number: NCT02127086

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Drug: Sugar pill
Drug: L-tetrahydropalmatine (30mg)

First Posted Date: 2014-04-21

Last Posted Date: 2022-01-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 63

Registration Number: NCT02118610

Locations: 🇺🇸
Maryland Psyciatric Research Center, Catonsville, Maryland, United States

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: Anastrozole
Drug: Letrozole

First Posted Date: 2014-03-24

Last Posted Date: 2025-05-15

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 42

Registration Number: NCT02095184

Locations: 🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States

Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Behavioral: Cognitive remediation training
Drug: Nicotine polacrilex lozenge

First Posted Date: 2014-02-24

Last Posted Date: 2019-09-12

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 31

Registration Number: NCT02069392

Locations: 🇺🇸
Maryland Psychiatric Research Center, Baltimore, Maryland, United States

Tryptophan MRI in People With Schizophrenia and Healthy Controls

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Tryptophan
Drug: Placebo

First Posted Date: 2014-02-20

Last Posted Date: 2024-07-30

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 93

Registration Number: NCT02067975

Locations: 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: Personal Approaches to Treatment Choices for HIV
Behavioral: Stress Reduction Skills Program

First Posted Date: 2014-02-05

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 50

Registration Number: NCT02055417

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System

Not Applicable

Active, not recruiting

Conditions: Unresectable Pancreatic Cancer

Interventions: Device: NanoKnife IRE System

First Posted Date: 2014-01-22

Last Posted Date: 2024-02-16

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 4

Registration Number: NCT02041936

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Telehome Monitoring for Chronic Disease Management

Not Applicable

Completed

Conditions: Diabetes Mellitus
Heart Failure
Hypertension
Pulmonary Disease, Chronic Obstructive

Interventions: Other: Telehome Care Monitoring

First Posted Date: 2014-01-14

Last Posted Date: 2022-01-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 23

Registration Number: NCT02035566

Locations: 🇺🇸
Chesapeake-Potomac Home Health Agency, Hughesville, Maryland, United States
🇺🇸
Garrett County Health Department Home Health Agency, Oakland, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy